☰ Navigation Tabs
Site 2 insulin receptor binding peptide IM459N21
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 2D 1H-1H COSY 20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide 95% H2O/5% D2O 100 mM 7.4 1 atm 298 Bruker AVANCE III 600 2 2D 1H-1H TOCSY 20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide 95% H2O/5% D2O 100 mM 7.4 1 atm 298 Bruker AVANCE III 600 3 2D 1H-1H NOESY 20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide 95% H2O/5% D2O 100 mM 7.4 1 atm 298 Bruker AVANCE III 600 4 2D 1H-1H NOESY 20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide 95% H2O/5% D2O 100 mM 7.4 1 atm 298 Bruker AVANCE III 600 5 2D 1H-13C HSQC aliphatic 20 mM [U-2H] Tris, 100 mM sodium chloride, 0.75 mM peptide 95% H2O/5% D2O 100 mM 7.4 1 atm 298 Bruker AVANCE III 600
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE III 600
NMR Refinement Method Details Software molecular dynamics GROMACS
NMR Ensemble Information Conformer Selection Criteria all calculated structures submitted Conformers Calculated Total Number 16 Conformers Submitted Total Number 16 Representative Model 1 (fewest violations)
Computation: NMR Software # Classification Version Software Name Author 1 refinement GROMACS 5.0.7 Mark Abraham, Berk Hess, David van der Spoel, and Erik Lindahl 2 structure calculation GROMACS 5.0.7 Mark Abraham, Berk Hess, David van der Spoel, and Erik Lindahl 3 chemical shift assignment CcpNmr Analysis 2 CCPN 4 peak picking CcpNmr Analysis 2 CCPN